Peter Izmirly
Impact in
- Rheumatology top 0.2%
- Systemic Lupus Erythematosus Research
- Immunology top 2%
- Reproductive System and Pregnancy
- Atherosclerosis and Cardiovascular Diseases
- T-cell and B-cell Immunology
Papers in
- Rheumatology 78
- Systemic Lupus Erythematosus Research 75
- Immunology 40
- Atherosclerosis and Cardiovascular Diseases 19
- T-cell and B-cell Immunology 11
- Immunodeficiency and Autoimmune Disorders 6
- Co-authors
- Jill P. BuyonAmit SaxenaMimi KimDeborah FriedmanCarolina LlanosRobert M. ClancyMunther A. KhamashtaAnca Askanase
- Journals
- Lupus Science & Medicine (10 papers)Annals of the Rheumatic Diseases (10 papers)Arthritis & Rheumatology (9 papers)Lara D. Veeken (6 papers)The Journal of Rheumatology (5 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Peter Izmirly
90 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 106
- Rheumatology 2.1k
- Immunology 1.4k
- Nephrology 217
- Cardiology and Cardiovascular Medicine 578
- Infectious Diseases 446
Countries citing papers authored by Peter Izmirly
This map shows the geographic impact of Peter Izmirly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Izmirly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Izmirly more than expected).
Fields of papers citing papers by Peter Izmirly
This network shows the impact of papers produced by Peter Izmirly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Izmirly. The network helps show where Peter Izmirly may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Izmirly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 33 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 3 | |
| 7 | 2021 | 25 | |
| 8 | 2020 | 20 | |
| 9 | COVID-19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and DMARDs on Clinical Outcomes | 2020 | 10 |
| 10 | 2020 | 95 | |
| 11 | 2020 | 101 | |
| 12 | 2020 | 24 | |
| 13 | 2019 | 43 | |
| 14 | 2018 | 30 | |
| 15 | 2015 | 25 | |
| 16 | 2015 | 48 | |
| 17 | 2014 | 66 | |
| 18 | 2012 | 34 | |
| 19 | 2010 | 66 | |
| 20 | 2008 | 20 |
About Peter Izmirly
Peter Izmirly is a scholar working on Rheumatology, Immunology, Nephrology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 97 papers that have together received 3.6k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (75 papers), Atherosclerosis and Cardiovascular Diseases (19 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), T-cell and B-cell Immunology (11 papers), Diabetes and associated disorders (10 papers), Renal Diseases and Glomerulopathies (9 papers), Viral Infections and Immunology Research (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). The work is most often cited by research in Rheumatology (2.1k citations), Immunology (1.4k citations), Nephrology (217 citations), Cardiology and Cardiovascular Medicine (578 citations) and Infectious Diseases (446 citations). Peter Izmirly has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Jill P. Buyon, Amit Saxena, Mimi Kim, Deborah Friedman, Carolina Llanos, Robert M. Clancy, Munther A. Khamashta, Anca Askanase, H. Michael Belmont and Pilar Brito‐Zerón. Their work appears in journals such as Lupus Science & Medicine, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Lara D. Veeken and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.